John Batsis, M.D.

Associate Professor

UNC-Chapel Hill
Clinical Aging Research
Clinical Trials
Dementia Care
Epidemiology & Population Health
Clinical: Geriatric Medicine, Obesity, Health Promotion, Frailty Research: Obesity and Physical Function in Older Adults; Using technology (telemedicine, remote monitoring) to enhance health in older adults

Miles Berger, MD, PhD

Associate Core Leader

Duke University
Alzheimer’s Disease
Bioinformatics
Clinical Trials
Cognition
Neurodegeneration
Neuroimaging
Neuroinflammation
Neuropharmacology
Research interests include: Delirium, Postoperative Neurocognitive Disorders, APOE4 biology, Multi-omic studies

Andrea Bozoki, MD

Core Leader

UNC-Chapel Hill
Alzheimer’s Disease
Clinical Trials
Neurodegeneration

John Buse, M.D, Ph.D.

Professor

UNC-Chapel Hill
Alzheimer’s Disease
Behavioral Pathology
Clinical Trials
Cognition
The UNC Endocrinology Diabetes Obesity Clinical Research Unit (ENDO CRU) is a leading site for clinical and translational studies of diabetes, obesity and its complications. We are well positioned to help apply diabetes treatments to cognitive disorders and recruit patients with diabetes and obesity to AD translational studies.

Jamie Capal, M.D.

UNC-Chapel Hill
Biomarkers
Clinical Trials
Genetics
Research interests include studying neurodevelopmental disorders across the lifespan, including Down syndrome, Fragile X syndrome, Angelman syndrome, and Tuberous Sclerosis Complex, and the relationship between early neurodevelopmental conditions and later neurodegeneration.

Michael Devinney, M.D, Ph.D.

Associate Core Leader

Duke University
Clinical Trials
Delirium and cognitive dysfunction following surgery are associated with significant long-term risk for dementia, diminished quality of life, and increased mortality. To better understand the relationship between OSA, postoperative neurocognitive disorders and neuroinflammation, we are carrying out a prospective observational cohort study called Sleep Apnea, Neuroinflammation, and cognitive Dysfunction Manifesting After Non-cardiac surgery (SANDMAN).

Murali Doraiswamy, M.B.B.S.

Duke University
Biomarkers
Clinical Trials
Precision Medicine; Digital Therapeutics; Biomarkers; Clinical Trials; Aging; Artificial Intelligence in Medicine

Dilraj Grewal, M.D.

Duke University
Artificial Intelligence
Biomarkers
Clinical Trials
Dilraj Grewal, MD specializes in the medical and surgical management of patients with complex Vitreoretinal pathology and Uveitis and is a Director of Grading at the Duke Reading Center. His research focus is on 1) Novel Retinal Imaging endpoints in Alzheimer’s and other neurodegenerative diseases 2) Leveraging the use of artificial intelligence to create risk stratification models based on retinal imaging 3) Modeling longitudinal rates of change in retinal imaging in Alzheimer’s and other neurodegenerative diseases to establish potential anatomical endpoints to incorporate into clinical trials.

Jeffrey Guptill, M.D.

Duke University
Biomarkers
Clinical Trials

Melissa Harris-Gersten, PhD, RN

Clinical Associate in the School of Nursing

Duke University
Clinical Trials
REC Scholar Project: Development of a Dyadic Stress Management Toolkit for Dementia Caring Dyads

Shivanand Lad, M.D, Ph.D.

Duke University
Clinical Trials
Neuromodulation; Neurorestoration; Bioengineering; Medical Device Design; Clinical Trials; Data Science; Health Outcomes.

Eleonora Lad, Ph.D., M.D.

Duke University
Biomarkers
Clinical Trials
1) investigating the role of neuroinflammation and abnormal protein aggregates in the pathogenesis of AMD and developing relevant treatments 2) visual function testing in dry AMD with the goal of establishing functional endpoints for future clinical studies in early AMD 3) elucidating the use of novel retinal imaging biomarkers for early diagnosis of aging diseases (AMD and Alzheimer’s disease), including through the use of artificial intelligence (machine and deep learning).

Milta Little, D.O.

Duke University
Clinical Trials

Richard O’Brien, MD, PhD

Core Leader

Duke University
Clinical Trials
Cognition
Neurodegeneration

Darina Petrovsky, PhD, RN

Assistant Professor of Nursing, Division of Women, Children, and Families

Duke University
Alzheimer’s Disease
Care Givers & Community Support
Clinical Trials
Dementia Care
I am funded on a K23 from the NIA and the Alzheimer’s Association to examine the impact of music-based interventions on sleep in persons living with dementia and their caregivers.

Anthony Sung, M.D.

Duke University
Clinical Trials
Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections.

Dennis Turner, M.D.

Duke University
Clinical Trials
Clinical trials in Parkinson disease, Alzheimer disease, translational research in Parkinson disease, tremor, stroke, and preclinical studies on Alzheimer’s disease models, stroke, metabolism, and cerebral blood flow.